LFCRLIFECORE BIOMEDICAL, INC. \DE\

Nasdaq www.landec.com


$ 6.39 $ 0.04 (0.63 %)    

Friday, 03-May-2024 15:59:50 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 6.39
$ 6.44
$ 6.37 x 200
$ 6.40 x 200
$ 6.28 - $ 6.46
$ 4.13 - $ 11.46
113,355
na
191.43M
$ 0.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-20-2024 05-28-2023 10-K
2 06-02-2023 02-26-2023 10-Q
3 03-16-2023 11-27-2022 10-Q
4 10-07-2022 08-28-2022 10-Q
5 09-14-2022 05-29-2022 10-K
6 04-07-2022 02-27-2022 10-Q
7 01-07-2022 11-28-2021 10-Q
8 10-05-2021 08-29-2021 10-Q
9 07-29-2021 05-30-2021 10-K
10 04-08-2021 02-28-2021 10-Q
11 01-07-2021 11-29-2020 10-Q
12 10-07-2020 08-30-2020 10-Q
13 08-14-2020 05-31-2020 10-K
14 04-03-2020 02-23-2020 10-Q
15 01-02-2020 11-24-2019 10-Q
16 10-03-2019 08-25-2019 10-Q
17 08-01-2019 05-26-2019 10-K
18 04-04-2019 02-24-2019 10-Q
19 01-07-2019 11-25-2018 10-Q
20 10-05-2018 08-26-2018 10-Q
21 08-09-2018 05-27-2018 10-K
22 04-05-2018 02-25-2018 10-Q
23 01-05-2018 11-26-2017 10-Q
24 09-28-2017 08-27-2017 10-Q
25 08-11-2017 05-28-2017 10-K
26 04-07-2017 02-26-2017 10-Q
27 01-05-2017 11-27-2016 10-Q
28 09-29-2016 08-28-2016 10-Q
29 08-01-2016 05-29-2016 10-K
30 03-30-2016 02-28-2016 10-Q
31 01-07-2016 11-29-2015 10-Q
32 10-01-2015 08-30-2015 10-Q
33 07-31-2015 05-31-2015 10-K
34 04-02-2015 03-01-2015 10-Q
35 01-09-2015 11-30-2014 10-Q
36 10-08-2014 08-31-2014 10-Q
37 08-01-2014 05-25-2014 10-K
38 03-28-2014 02-23-2014 10-Q
39 01-03-2014 11-24-2013 10-Q
40 09-26-2013 08-25-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lifecore-biomedical-inc-receives-notice-from-nasdaq-regarding-delayed-quarterly-report-for-the-fiscal-quarter-ended-february-25-2024-and-its-continued-delay-in-filing-its-quarterly-report-on-form-10-q-for-the-quarterly-periods-ended-august-27-2023-and-november-29-2023

Lifecore Biomedical, Inc. (NASDAQ:LFCR) (the "Company") announced today that, on April 15, 2024, the Company received a...

 dow-surges-350-points-fed-holds-rates-steady

U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% t...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

 crude-oil-dips-2-signet-jewelers-shares-spike-higher

U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow trade...

 us-stocks-edge-lower-ahead-of-feds-decision-general-mills-earnings-top-views

U.S. stocks traded slightly lower this morning, ahead of interest-rate decision from the Federal Reserve. Following the market...

Core News & Articles

Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore re...

 top-5-risk-off-stocks-that-may-explode-this-quarter

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

 lifecore-biomedical-inc-reaches-favorable-resolution-regarding-previously-disclosed-investigation-of-formerly-held-subsidiary-yucatan-foods-lifecore-has-agreed-to-pay-disgorgement-in-the-amount-of-406505

Lifecore Biomedical, Inc. (NASDAQ:LFCR) (the "Company") announced today that the U.S. Department of Justice (the "D...

 lifecore-biomedical-inc-receives-notice-from-nasdaq-regarding-delayed-annual-report

Lifecore Biomedical, Inc. (NASDAQ:LFCR) (the "Company") announced today that it received a notice ("Notice") on...

 lifecore-biomedical-provides-update-for-development-portfolio-and-timing-of-delayed-filings-anticipates-reporting-its-fy24-q1-results-in-late-october-or-early-november-pending-completion-of-its-annual-audit

Lifecore Biomedical, Inc. ("Lifecore" or the "Company"), a fully integrated contract development and manufactur...

 barrington-research-maintains-outperform-on-lifecore-biomedical-lowers-price-target-to-10

Barrington Research analyst Michael Petusky maintains Lifecore Biomedical (NASDAQ:LFCR) with a Outperform and lowers the pri...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION